| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |